Annual Accounts Payable
$5.28 M
-$2.17 M-29.13%
31 December 2023
Summary:
Arcturus Therapeutics Holdings annual accounts payable is currently $5.28 million, with the most recent change of -$2.17 million (-29.13%) on 31 December 2023. During the last 3 years, it has fallen by -$5.50 million (-51.00%). ARCT annual accounts payable is now -51.00% below its all-time high of $10.77 million, reached on 31 December 2020.ARCT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$10.13 M
-$3.77 M-27.14%
30 September 2024
Summary:
Arcturus Therapeutics Holdings quarterly accounts payable is currently $10.13 million, with the most recent change of -$3.77 million (-27.14%) on 30 September 2024. Over the past year, it has dropped by -$8.23 million (-44.83%). ARCT quarterly accounts payable is now -47.63% below its all-time high of $19.34 million, reached on 31 March 2023.ARCT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARCT Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.1% | -44.8% |
| 3 y3 years | -51.0% | +22.6% |
| 5 y5 years | +120.1% | +152.4% |
ARCT Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -51.0% | at low | -47.6% | +91.9% |
| 5 y | 5 years | -51.0% | +120.1% | -47.6% | +168.1% |
| alltime | all time | -51.0% | >+9999.0% | -47.6% | >+9999.0% |
Arcturus Therapeutics Holdings Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $10.13 M(-27.1%) |
| June 2024 | - | $13.90 M(+52.1%) |
| Mar 2024 | - | $9.14 M(+73.2%) |
| Dec 2023 | $5.28 M(-29.1%) | $5.28 M(-71.3%) |
| Sept 2023 | - | $18.36 M(+34.8%) |
| June 2023 | - | $13.62 M(-29.6%) |
| Mar 2023 | - | $19.34 M(+159.7%) |
| Dec 2022 | $7.45 M(-25.9%) | $7.45 M(-58.5%) |
| Sept 2022 | - | $17.96 M(+211.7%) |
| June 2022 | - | $5.76 M(-42.5%) |
| Mar 2022 | - | $10.01 M(-0.4%) |
| Dec 2021 | $10.06 M(-6.6%) | $10.06 M(+21.7%) |
| Sept 2021 | - | $8.27 M(-18.0%) |
| June 2021 | - | $10.08 M(+80.2%) |
| Mar 2021 | - | $5.60 M(-48.1%) |
| Dec 2020 | $10.77 M(+86.0%) | $10.77 M(+66.3%) |
| Sept 2020 | - | $6.48 M(+47.4%) |
| June 2020 | - | $4.39 M(+16.3%) |
| Mar 2020 | - | $3.78 M(-34.8%) |
| Dec 2019 | $5.79 M(+141.6%) | $5.79 M(+44.4%) |
| Sept 2019 | - | $4.01 M(+25.9%) |
| June 2019 | - | $3.19 M(-22.6%) |
| Mar 2019 | - | $4.12 M(+71.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $2.40 M(+34.0%) | $2.40 M(-17.5%) |
| Sept 2018 | - | $2.90 M(+4.5%) |
| June 2018 | - | $2.78 M(+55.4%) |
| Dec 2017 | $1.79 M(-46.7%) | $1.79 M(+4872.2%) |
| Sept 2017 | - | $36.00 K(+89.5%) |
| June 2017 | - | $19.00 K(-96.1%) |
| Mar 2017 | - | $488.00 K(-85.5%) |
| Dec 2016 | $3.36 M(+5789.5%) | $3.36 M(+2108.6%) |
| Sept 2016 | - | $152.00 K(+10.1%) |
| June 2016 | - | $138.00 K(+24.3%) |
| Mar 2016 | - | $111.00 K(+94.7%) |
| Dec 2015 | $57.00 K(-81.3%) | $57.00 K(-89.2%) |
| Sept 2015 | - | $527.00 K(+227.3%) |
| June 2015 | - | $161.00 K(-47.2%) |
| Dec 2014 | $305.00 K(+548.9%) | $305.00 K(-80.1%) |
| Sept 2014 | - | $1.53 M(+5.1%) |
| June 2014 | - | $1.46 M(+3.4%) |
| Mar 2014 | - | $1.41 M(+2897.9%) |
| Dec 2013 | $47.00 K(+104.3%) | $47.00 K(+51.6%) |
| Sept 2013 | - | $31.00 K(-53.7%) |
| June 2013 | - | $67.00 K(+191.3%) |
| Dec 2012 | $23.00 K(-81.5%) | $23.00 K |
| Dec 2011 | $124.00 K | - |
FAQ
- What is Arcturus Therapeutics Holdings annual accounts payable?
- What is the all time high annual accounts payable for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings annual accounts payable year-on-year change?
- What is Arcturus Therapeutics Holdings quarterly accounts payable?
- What is the all time high quarterly accounts payable for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings quarterly accounts payable year-on-year change?
What is Arcturus Therapeutics Holdings annual accounts payable?
The current annual accounts payable of ARCT is $5.28 M
What is the all time high annual accounts payable for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high annual accounts payable is $10.77 M
What is Arcturus Therapeutics Holdings annual accounts payable year-on-year change?
Over the past year, ARCT annual accounts payable has changed by -$2.17 M (-29.13%)
What is Arcturus Therapeutics Holdings quarterly accounts payable?
The current quarterly accounts payable of ARCT is $10.13 M
What is the all time high quarterly accounts payable for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high quarterly accounts payable is $19.34 M
What is Arcturus Therapeutics Holdings quarterly accounts payable year-on-year change?
Over the past year, ARCT quarterly accounts payable has changed by -$8.23 M (-44.83%)